Further study is needed with a large cohort to emphasize importance of alteration.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:OBJECTIVEThe aim of the present study was to identify the prevalence of PALB2 gene mutations in patients diagnosed with pancreatic cancer in Turkish population, and to investigate the role of PALB2 in the pathogenesis of the disease.METHODSThirty patients diagnosed with pancreatic cancer and 30 healthy controls who had no cancer history intheir family and matched for age, gender, and ethnicity with the patients were analyzed in the study.
📊
Key Findings & Data:Theexome regions of the PALB2 gene in the genomic DNA obtained from the peripheral blood samples ofthe patients and controls were investigated by the Sanger sequencing method.RESULTSEvaluation of the obtained data showed that the alterations of c.29G>T, c.2737C>A, c.2773G>C, andc.2840T>G were only identified in the group of patient; and the alteration of c.1676A>G was detected inthe homozygous formation in the case with a familial pancreatic cancer syndrome in the group of patient.CONCLUSIONThese alterations were suggested to be possibly important in the pathogenesis, and in the inheritance ofpancreatic cancer.
💡
Conclusion & Impact:Further study is needed with a large cohort to emphasize importance of alteration.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
OBJECTIVEThe aim of the present study was to identify the prevalence of PALB2 gene mutations in patients diagnosed with pancreatic cancer in Turkish population, and to investigate the role of PALB2 in the pathogenesis of the disease.METHODSThirty patients diagnosed with pancreatic cancer and 30 healthy controls who had no cancer history intheir family and matched for age, gender, and ethnicity with the patients were analyzed in the study. Theexome regions of the PALB2 gene in the genomic DNA obtained from the peripheral blood samples ofthe patients and controls were investigated by the Sanger sequencing method.RESULTSEvaluation of the obtained data showed that the alterations of c.29G>T, c.2737C>A, c.2773G>C, andc.2840T>G were only identified in the group of patient; and the alteration of c.1676A>G was detected inthe homozygous formation in the case with a familial pancreatic cancer syndrome in the group of patient.CONCLUSIONThese alterations were suggested to be possibly important in the pathogenesis, and in the inheritance ofpancreatic cancer. Further study is needed with a large cohort to emphasize importance of alteration.
🔖
Cite This Article
ÖDEMİŞ, D. A., ERDOĞAN, Ö. Ş., KAYTAN, E., AVŞAR, M., TAŞTEKİN, D., TÜRKCAN, G. K., ERCİYAS, S. K., KARABULUT, S., TUNÇER, Ş. B., YAZICI, H. (2022). The Association of Pancreatic Cancer and PALB2 Gene Mutations in the Turkish Population. Türk Onkoloji Dergisi, Cilt: 34 - Sayı: 4, 283–290. https://ajindex.com/articles/639207
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424
Matthaios D, Zarogoulidis P, Balgouranidou I, Chatzaki E, Kakolyris S. Molecular pathogenesis of pancreatic cancer and clinical perspectives. Oncology 2011;81(3-4):259–72
Solomon S, Das S, Brand R, Whitcomb DC. Inherited pancreatic cancer syndromes. Cancer J 2012;18(6):485–91
Zhan W, Shelton CA, Greer PJ1, Brand RE, Whitcomb DC. Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts. Pancreas 2018;47(8):924–36
Chaffee KG, Oberg AL, McWilliams RR, Majithia N, Allen BA, Kidd J, et al. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet Med 2018;20(1):119–27
Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al; Breast Cancer Susceptibility Collaboration (UK). PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 2007;39(2):165–7
Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324(5924):217
Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res 201115;71(6):2222–9
Pauty J, Rodrigue A, Couturier A, Buisson R, Masson JY. Exploring the roles of PALB2 at the crossroads of DNA repair and cancer. Biochem J 2014;460(3):331–42. 10.Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010;40(2):179–204. 11.Moynahan ME, Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 2010;11(3):196–207. 12.Sy SM, Huen MS, Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci U S A 2009;106(17):7155–60. 13.Zhang F, Fan Q, Ren K, Andreassen PR. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol Cancer Res 2009 Jul;7(7):1110–8. 14.Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B, et al. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol 2009;19(6):524–9. 15.Tischkowitz M, Xia B. PALB2/FANCN: recombining cancer and